Surgical robotics companies are developing products for a variety of surgery types, including cardiac, spinal and endoluminal surgeries. The tools these firms provide can increase surgeons’ performance ability and can lessen scarring, incisions, blood loss and more. They can also make surgeries safer and lead to a more comfortable recovery.
Here the Investing News Network takes a closer look at robotic surgery stocks, from the biggest names in the industry to lesser-known companies that are still working on product development.
Market cap: US$171.48 billion; share price: US$482.55
First on this list of surgical robotics stocks is Intuitive Surgical, the company behind the da Vinci system. Its this system that has made it a global leader in surgical robotics, as well as one of the best-known surgical robotics companies. Started in 1999, the da Vinci system is used internationally as an aid in cardiac, thoracic, urology, gynecologic, colorectal, pediatric and general surgeries.
Market cap: US$138.59 billion; share price: US$363.69
Stryker is responsible for the Mako robotic arm system for assisted joint replacement surgery, which can be used in partial knee, total hip and total knee surgeries.
Market cap: US$116.35 billion; current share price: US$90.73
Third on this list of medical robotics stocks is Ireland-based Medtronic, one of the world’s largest medical technology companies. The company’s portfolio of medical devices includes surgical, respiratory, patient-monitoring, gastrointestinal and hepatology, lung health and renal care products.
Market cap: US$68.04 billion; share price: US$235.39
Becton Dickinson’s software solution BD Cato can be integrated into existing hospital IT infrastructure, and allows for the inclusion of robotic compounding devices into these ecosystems. In fact, several hospitals in Europe have been able to implement system interfaces between BD Cato and the robotic compounding system APOTECA.
Market cap: US$21.39 billion; share price: US$105.02
Global medical technology leader Zimmer Biomet Holdings has a suite of innovative products and integrated digital and robotic technologies that incorporate data analytics and artificial intelligence to provide real-time insights. Its multi-application ROSA robotics platform assists surgeons in performing procedures in a minimally invasive manner.
Zimmer Biomet’s ROSA robotics platform features the ROSA ONE Brain to assist surgeons in planning and performing complex neurosurgical procedures, and the ROSA Knee system to support surgeons when performing total knee replacements, including assisting with bone resections and assessment of soft tissue state.
Market cap: US$13.77 billion; current share price: US$31.64
Known for orthopedic reconstruction, advanced wound management, sports medicine and more, Smith & Nephew is behind the Navio surgical system. Navio works for both partial and total knee replacement procedures.
Market cap: US$9.41 billion; current share price: US$69.48
Globus Medical develops and commercializes spinal and orthopedic implants and surgical instruments that help surgeons treat patients with musculoskeletal disorders. It offers the ExcelsiusGPS robotic navigation platform.
Market cap: US$3.996 billion; current share price: US$76.94
The last surgical robotics company on this list is San Jose, California-based Procept BioRobotics. With an initial focus on applications in urology, the commercial-stage company has developed its AquaBeam Robotic System, the first surgical robot providing autonomous tissue removal for the treatment of benign prostatic hyperplasia, more commonly known as enlarged prostate.
“We are pleased to bring the HYDROS Robotic System to the U.S. market. This milestone marks a pivotal moment for PROCEPT as Aquablation therapy continues its rapid adoption, with over 400 robotic systems now installed across the United States,” PROCEPT BioRobotics CEO Reza Zadno said.
This is an updated version of an article first published by the Investing News Network in 2018.
Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.
Leave a Reply